Role of Multidisciplinary Team in the Management of Patients with HER2+ BC and CNS Metastases
July 8th 2022Highlighting the importance of a multidisciplinary approach to care in HER2+ mBC, Vijayakrishna Gadi, MD, PhD, describes the value of effective consultation with neurooncologists and radiation oncologists for CNS metastases.
Read More
Selecting and Sequencing Therapy in Patients with HER2+ mBC and CNS Metastases
July 1st 2022An expert oncologist reviews key considerations in selecting and sequencing treatment appropriately in patients with HER2+ breast cancer and CNS metastases, including challenges associated with treating leptomeningeal disease.
Read More